Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)

Clinical trial NCT05302037 · RECRUITING

Trial details

NCT number: NCT05302037
Sponsor: CytoMed Therapeutics Pte Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Malignancy Refractory Cancer Relapsed Cancer

Start date: 2024-11-19
Primary completion: 2025-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.